MedTrace Logo

Impact of Nebivolol on Central Aortic Pressure

NCT01051947 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2011-08-01

No results posted yet for this study

Summary

A randomized, cross-over, single-blind study to compare the effects of nebivolol and metoprolol on central aortic pressure and peripheral brachial pressure in patients with stable cardiovascular disease.

Conditions

  • Central Aortic Pressure

Interventions

DRUG

Nebivolol

10 mg by mouth daily for 2 weeks 20 mg by mouth daily for 2 weeks 40 mg by mouth daily for 2 weeks

DRUG

Metoprolol

dosage prescribed prior to starting on study

Sponsors & Collaborators

  • Creighton University

    lead OTHER

Principal Investigators

  • Jennifer Campbell, PharmD · Creighton University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01051947 on ClinicalTrials.gov